Skip to main content
TipRanks
Go Ultimate75% OFF

Ampio Pharmaceuticals (AMPE) Stock Price & Analysis

505 Followers

AMPE Stock Chart & Stats

$0.18$0.00(0.00%)
At close: 4:00 PM EST
$0$0.25$0.5Feb 24Mar 10Mar 23Apr 14Apr 20May 7
Day’s Range
$0.18 - $0.18
52-Week Range
$0.01 - $0.64
Previous Close
$0.18
Volume
N/A
Average Volume (3M)
0
Market Cap
$207.88K
Enterprise Value
-$3.61T
Total Cash (Recent Filing)
$4.09M
Total Debt (Recent Filing)
$274.00K
Price to Earnings (P/E)
―
Beta
42.76
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Low leverage indicates that the company has not overburdened itself with debt, which can be advantageous in maintaining financial flexibility and reducing risk during periods of financial distress.

Asset Stability

Maintaining a positive equity ratio suggests that despite financial challenges, the company has managed to keep its assets stable, which is crucial for long-term operational sustainability.

Innovative Treatment Approach

Focusing on innovative treatments for prevalent conditions like osteoarthritis positions Ampio to potentially capture significant market share if successful, providing a strong foundation for future growth.

Bears Say

Zero Revenue

The lack of revenue generation over an extended period highlights significant challenges in commercializing products, which is critical for sustaining operations and achieving profitability.

Negative Cash Flow

Persistent negative cash flow indicates the company struggles to generate sufficient cash from its operations, posing risks to its ability to finance ongoing activities and future growth.

Ongoing Losses

Continued operating losses suggest difficulties in achieving profitability, which can hinder the company's ability to invest in research, development, and expansion efforts.

Ampio Pharmaceuticals News

AMPE FAQ

What was Ampio Pharmaceuticals’s price range in the past 12 months?
Ampio Pharmaceuticals lowest stock price was $0.01 and its highest was $0.64 in the past 12 months.
What is Ampio Pharmaceuticals’s market cap?
Ampio Pharmaceuticals’s market cap is $207.88K.
When is Ampio Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ampio Pharmaceuticals’s earnings last quarter?
Ampio Pharmaceuticals released its earnings results on May 11, 2023. The company reported -$0.264 earnings per share for the quarter.
Is Ampio Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Ampio Pharmaceuticals pay dividends?
Ampio Pharmaceuticals does not currently pay dividends.
What is Ampio Pharmaceuticals’s EPS estimate?
Ampio Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ampio Pharmaceuticals have?
Ampio Pharmaceuticals has 1,135,358 shares outstanding.
What happened to Ampio Pharmaceuticals’s price movement after its last earnings report?
Ampio Pharmaceuticals reported an EPS of -$0.264 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ampio Pharmaceuticals?
Currently, no hedge funds are holding shares in AMPE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology